Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
ACS Chem Neurosci. 2023 Jul 20. doi: 10.1021/acschemneuro.3c00264. Online ahead of print.
ABSTRACT
Catalytic photo-oxygenation of tau amyloid is a potential therapeutic approach to tauopathies, including Alzheimer disease (AD). However, tau is a complex target containing great molecular size and heterogeneous isoforms/proteoforms. Although catalytic photo-oxygenation has been confirmed when using catalyst 1 and recombinant tau pretreated with heparin, its effects on tau from human patients have not yet been clarified. In this study, focusing on the histidine residues being oxygenated, we have constructed two assay systems capable of quantitatively evaluating the catalytic activity when used on human patient tau: (1) fluorescence labeling at oxygenated histidine sites and (2) LC-MS/MS analysis of histidine-containing fragments. Using these assays, we identified 2 as a promising catalyst for oxygenation of human tau. In addition, our results suggest that aggregated tau induced by heparin is different from actual AD patient tau in developing effective photo-oxygenation catalysts.
PMID:37470225 | DOI:10.1021/acschemneuro.3c00264
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models In vivo PET classification of tau pathologies in patients with frontotemporal dementia Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3 Precision proteoform design for 4R tau isoform selective templated aggregation Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy Tau follows principal axes of functional and structural brain organization in Alzheimer's disease Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold Autophagy and exosomes; inter-connected maestros in Alzheimer's disease Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient Pongamol Alleviates Neuroinflammation and Promotes Autophagy in Alzheimer's Disease by Regulating the Akt/mTOR Signaling Pathway Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer's disease Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Coeruleus Degeneration and Hippocampal Amyloid-β42 Accumulation Genomic stress and impaired DNA repair in Alzheimer disease A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects Tau propagation in the brain olfactory circuits is associated with smell perception changes in aging Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy Hyperphosphorylated tau in Alzheimer's disease disseminates along pathways predicted by the Structural Model for Cortico-cortical Connections Overexpression of pathogenic tau in astrocytes causes a reduction in AQP4 and GLT1, an immunosuppressed phenotype and unique transcriptional responses to repetitive mild TBI without appreciable changes in tauopathy Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease Personalized whole-brain neural mass models reveal combined Ab and tau hyperexcitable influences in Alzheimer's disease Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies How can we manage progressive supranuclear palsy syndrome with pharmacotherapy? Sleep disruption precedes forebrain synaptic Tau burden and contributes to cognitive decline in a sex-dependent manner in the P301S Tau transgenic mouse model Towards cascading genetic risk in Alzheimer's disease Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study Physical activity may a probably protective factor for postoperative delirium: the PNDABLE study Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers Brain injury plasma biomarkers in patients on veno-arterial extracorporeal membrane oxygenation: A pilot prospective observational study Total Tau Protein Mediates the Association of Ischemic Cerebrovascular Disease with Cognitive Decline Detection of individual brain tau deposition in Alzheimer's disease based on latent feature-enhanced generative adversarial network Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases Evaluating the efficacy of artificial intelligence chatbots in urological health: insights for urologists on patient interactions with large language models Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression The Rational Design of Atomically Dispersed Catalysts via Spin Manipulation Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation Passive immunotherapy for Alzheimer's disease: challenges & future directions Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
Evidence Blueprint
Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry Tau and Alzheimer's disease: Past, present and future Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease Discovery of Orally Available and Brain Penetrant AEP Inhibitors Passive tau-based immunotherapy for tauopathies The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome Tau seeding without tauopathy G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission Selection of lansoprazole from an FDA-approved drug library to inhibit the Alzheimer's disease seed-dependent formation of tau aggregates Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein New insights into the therapeutic approaches for the treatment of tauopathies G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults A data-driven study of Alzheimer's disease related amyloid and tau pathology progression Distinct tau folds initiate templated seeding and alter the post-translational modification profile Different Tau Fibril Types Reduce Prion Level In Chronically And De Novo Infected Cells Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers Local structural preferences in shaping tau amyloid polymorphism APOEε4 potentiates amyloid β effects on longitudinal tau pathology Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers Effects of heterologous human tau protein expression in yeast models of proteotoxic stress response Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry Lateral geniculate body is spared of tau pathology in Pick disease p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003 Detection, visualization and quantification of protein complexes in human Alzheimer's disease brains using proximity ligation assay Relationship between the tau protein and choroid plexus volume in Alzheimer's disease Self-Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models In vivo PET classification of tau pathologies in patients with frontotemporal dementia Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury Disentangling tau: One protein, many therapeutic approaches Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer's disease tau Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3 FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS) In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease Precision proteoform design for 4R tau isoform selective templated aggregation Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer's disease-related mouse models Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology Tau follows principal axes of functional and structural brain organization in Alzheimer's disease Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold